AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Predictive Oncology Inc. Director's Dealing 2013

Nov 27, 2013

35106_dirs_2013-11-27_4582f589-47f8-47d9-b7a4-c57c0f911af4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Skyline Medical Inc. (SKLN)
CIK: 0001446159
Period of Report: 2013-11-25

Reporting Person: DREYFUSS ARNON I (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-11-25	Common Stock, $.01 par value	P	25000	$0.27	Acquired	1603551	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $.01 par value	20000	Indirect
Common Stock, $.01 par value	20000	Indirect
Common Stock, $.01 par value	10000	Indirect
Common Stock, $.01 par value	10000	Indirect

Footnotes

F1: The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.

F2: Neither the Reporting Person nor a family member is the trustee of such trust.